The URL can be used to link to this page

Home My WebLink AboutReports - 2022.02.17 - 35415PORTFOLIO MONITORING REVIEW ______________________ February 2022 Short Form Summary OAKLAND COUNTY EMPLOYEES’ R ETIREMENT SYSTEM We identified the following companies which are subject to claims of fraud and/or misrepresentation during the period of January 8,2022,to February 4,2022.Information contained in this report is based upon the December 31,2021 data,which is the latest available from Northern Trust .We will continue to monitor these cases for any developments that could impact OCERS, including settlements. 2022 Short Form Summary of PSLRA Filings PSLRA & Derivative lawsuits Impact Recommendation Robinhood Markets, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. SharpSpring, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Reata Pharmaceuticals, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. DocuSign, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Meta Materials Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. KE Holdings,: ADS No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Talis Biomedical Corporation Unknown at this time.Will continue to monitor as portfolio data becomes available. First Solar, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Oak Street Health, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. FirstCash Holdings, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Volkswagen AG: ADS No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. NRx Pharmaceuticals, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Clarivate Plc No PSLRA recognized losses. OCERS held 7,283 shares at the end of the Class Period at an average cost of $26.36 per share, but made no purchases during the Class Period. Therefore, there were no PSLRA losses and no action was recommended. Bumble Inc.Unknown at this time.Will continue to monitor as portfolio data becomes available. Standard Lithium Ltd.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. 2022 Short Form Summary of PSLRA Filings PSLRA & Derivative lawsuits Impact Recommendation Shattuck Labs, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Electric Last Mile Solutions, Inc.Unknown at this time.Will continue to monitor as portfolio data becomes available. TAL Education Group: ADS No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. New Oriental Education & Tech Gp Inc.: ADS No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. 2022 Short Form Summary of PSLRA Filings PSLRA & Derivative lawsuits Impact Recommendation Meta Materials Inc.Unknown at this time.Will continue to monitor as portfolio data becomes available. Credit Suisse AG No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Bright Health Group, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Talkspace, Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended. Talis Biomedical Corporation Unknown at this time.Will continue to monitor as portfolio data becomes available. Goldman Sachs Group Inc.No PSLRA recognized losses.OCERS had no holdings during the relevant time period; therefore, no action was recommended.